NYC Startup Syntimmune Names Former Biogen Exec as New CEO Post author:Sam Post published:January 2, 2018 Post category:BioPharma Syntimmune has appointed Jean-Paul Kress as president and CEO. Source: BioSpace You Might Also Like Meet the 29-Year-Old Man Who Just Launched Biotech Startup Advanced Modular Instruments (AMI) January 26, 2017 Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to … November 21, 2017 CRISPR/Cas9 Startup Launches in Boston February 26, 2017
Meet the 29-Year-Old Man Who Just Launched Biotech Startup Advanced Modular Instruments (AMI) January 26, 2017
Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to … November 21, 2017
